Literature DB >> 30341732

Peroxisome proliferator-activated receptor α attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice.

Yu Lu1, Makoto Harada1,2, Yuji Kamijo3,4, Takero Nakajima1,5, Naoki Tanaka1,5, Eiko Sugiyama6, Mamoru Kyogashima7, Frank J Gonzalez8, Toshifumi Aoyama1.   

Abstract

Peroxisome proliferator-activated receptor α (PPARα) is involved in the regulation of fatty acid and cholesterol metabolism. A high-cholesterol (HC) diet increases the risk of developing cardiovascular diseases (CVD); however, it is unclear whether the toxic effects of cholesterol involve changes in thrombotic factor expression, and whether PPARα is necessary for such effects. To investigate this possibility, we fed a HC diet to wild-type (WT) and Ppara-null mice and measured cholesterol and triglyceride contents, liver histology, serum/plasma levels of coagulation factors, hepatic expression of the coagulation factors, liver/serum sulfatide levels, hepatic sulfatide metabolism, hepatic expression of lipid transporters, and hepatic oxidative stress and its relating enzymes. In Ppara-null mice, the HC diet caused triglyceride accumulation and exacerbated inflammation and oxidative stress in liver, increased levels of coagulation factors, including tissue factor, plasminogen activator inhibitor-1 and carboxypeptidase B2 in blood and liver, and decreased levels of anti-thrombotic sulfatides in serum and liver. These changes were much less marked in WT mice. These findings imply that cholesterol overload exerts its toxic effects at least in part by enhancing thrombosis, secondary to abnormal hepatic lipid metabolism, inflammation, and oxidative stress. Moreover, we reveal for the first time that PPARα can attenuate these toxic effects by transcriptional regulation of coagulation factors and sulfatides, in addition to its known effects of controlling lipid homeostasis and suppressing inflammation and oxidative stress. Therapies aimed at activating PPARα might prevent HC diet-induced CVD through modulating various pro- and anti-thrombotic factors.

Entities:  

Keywords:  Cardiovascular diseases; Coagulation factors; High-cholesterol diet; Peroxisome proliferator-activated receptor α (PPARα); Sulfatides

Mesh:

Substances:

Year:  2018        PMID: 30341732      PMCID: PMC6661123          DOI: 10.1007/s00204-018-2335-4

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  5 in total

1.  Madecassoside Inhibits Body Weight Gain via Modulating SIRT1-AMPK Signaling Pathway and Activating Genes Related to Thermogenesis.

Authors:  Boju Sun; Misa Hayashi; Maya Kudo; Lili Wu; Lingling Qin; Ming Gao; Tonghua Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-09       Impact factor: 5.555

2.  Critical role of peroxisome proliferator-activated receptor α in promoting platelet hyperreactivity and thrombosis under hyperlipidemia.

Authors:  Li Li; Jiawei Zhou; Shuai Wang; Lei Jiang; Xiaoyan Chen; Yangfan Zhou; Jingke Li; Jingqi Shi; Pu Liu; Zheyue Shu; Frank J Gonzalez; Aiming Liu; Hu Hu
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

3.  Coagulopathy in Malnourished Mice Is Sexually Dimorphic and Regulated by Nutrient-Sensing Nuclear Receptors.

Authors:  Geoffrey A Preidis; Krishnakant G Soni; Ji Ho Suh; Tripti Halder; Kang Ho Kim; Jong Min Choi; Feng Li; Sridevi Devaraj; Margaret E Conner; Cristian Coarfa; Sung Yun Jung; David D Moore
Journal:  Hepatol Commun       Date:  2020-10-22

4.  Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs.

Authors:  Stephanie Seneff; Greg Nigh; Anthony M Kyriakopoulos; Peter A McCullough
Journal:  Food Chem Toxicol       Date:  2022-04-15       Impact factor: 5.572

Review 5.  Review article: vascular effects of PPARs in the context of NASH.

Authors:  Sergi Guixé-Muntet; Louise Biquard; Gyongyi Szabo; Jean-François Dufour; Frank Tacke; Sven Francque; Pierre-Emmanuel Rautou; Jordi Gracia-Sancho
Journal:  Aliment Pharmacol Ther       Date:  2022-06-05       Impact factor: 9.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.